the aid library

Filter

268

FACTI Panel Interim Report

The High-Level Panel on International Financial Accountability, Transparency and Integrity for Achieving the 2030 Agenda (FACTI Panel) The High-Level Panel on International Financial Accountability, Transparency and Integrity for Achieving the 2030 Agenda (FACTI Panel) (2020) CC

The High-Level Panel on International Financial Accountability, Transparency and Integrity for Achieving the 2030 Agenda (FACTI Panel) was convened by the 74th President of United Nations General Assembly and the 75th President of the Economic and Social Council on 2 March 2020. The objective of the ... more

SDG Costing & Financing for Low-Income Developing Countries

Sachs, J.; G. McCord; N. Maennling et al. UN Sustainable Development Solutions Network (SDSN) (2019) CC

The Sustainable Development Goals (SDGs) call for major societal transformations that will require significant fiscal outlays as well as private investments. The fiscal outlays cover public investments, the public provision of social services, and social protection for vulnerable populations. The ke ... more

Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995-2015

Global Burden of Disease Health Financing Collaborator Network Lancet (2018) CC

Background: Comparable estimates of health spending are crucial for the assessment of health systems and to optimally deploy health resources. The methods used to track health spending continue to evolve, but little is known about the distribution of spending across diseases. We developed improved e ... more

Public financing of health in developing countries: a cross-national systematic analysis

Lu, C.; Schneider, M.T.; Gubbins, P.; Leach-Kemon, K.; Jamison, D.; Murray, C.J.L. (2010) CC

Government spending on health from domestic sources is an important indicator of a government's commitment to the health of its people, and is essential for the sustainability of health programmes. We aimed to systematically analyse all data sources available for government spending on health in dev ... more

Estimates of aid for reproductive, maternal, newborn, and child health: findings from application of the Muskoka2 method, 2002–17

Dingle, A.; Schäferhoff, M.; Borghi, J. et al. The Lancet (2020) CC

Background Four methods have previously been used to track aid for reproductive, maternal, newborn, and child health (RMNCH). At a meeting of donors and stakeholders in May, 2018, a single, agreed method was requested to produce accurate, predictable, transparent, and up-to-date estimates that coul ... d be used for analyses from both donor and recipient perspectives. Muskoka2 was developed to meet these needs. We describe Muskoka2 and present estimates of levels and trends in aid for RMNCH in 2002–17, with a focus on the latest estimates for 2017. Methods Muskoka2 is an automated algorithm that generates disaggregated estimates of aid for reproductive health, maternal and newborn health, and child health at the global, donor, and recipient-country levels. We applied Muskoka2 to the Organisation for Economic Co-operation and Development's Creditor Reporting System (CRS) aid activities database to generate estimates of RMNCH disbursements in 2002–17. The percentage of disbursements that benefit RMNCH was determined using CRS purpose codes for all donors except Gavi, the Vaccine Alliance; the UN Population Fund; and UNICEF; for which fixed percentages of aid were considered to benefit RMNCH. We analysed funding by donor for the 20 largest donors, by recipient-country income group, and by recipient for the 16 countries with the greatest RMNCH need, defined as the countries with the worst levels in 2015 on each of seven health indicators. Findings After 3 years of stagnation, reported aid for RMNCH reached $15·9 billion in 2017, the highest amount ever reported. Among donors reporting in both 2016 and 2017, aid increased by 10% ($1·4 billion) to $15·4 billion between 2016 and 2017. Child health received almost half of RMNCH disbursements in 2017 (46%, $7·4 billion), followed by reproductive health (34%, $5·4 billion), and maternal and newborn health (19%, $3·1 billion). The USA ($5·8 billion) and the UK ($1·6 billion) were the largest bilateral donors, disbursing 46% of all RMNCH funding in 2017 (including shares of their core contributions to multilaterals). The Global Fund and Gavi were the largest multilateral donors, disbursing $1·7 billion and $1·5 billion, respectively, for RMNCH from their core budgets. The proportion of aid for RMNCH received by low-income countries increased from 31% in 2002 to 52% in 2017. Nigeria received 7% ($1·1 billion) of all aid for RMNCH in 2017, followed by Ethiopia (6%, $876 million), Kenya (5%, $754 million), and Tanzania (5%, $751 million). Interpretation Muskoka2 retains the speed, transparency, and donor buy-in of the G8's previous Muskoka approach and incorporates eight innovations to improve precision. Although aid for RMNCH increased in 2017, low-income and middle-income countries still experience substantial funding gaps and threats to future funding. Maternal and newborn health receives considerably less funding than reproductive health or child health, which is a persistent issue requiring urgent attention. Funding Bill & Melinda Gates Foundation; Partnership for Maternal, Newborn & Child Health. more

National spending on health by source for 184 countries between 2013 and 2040

Dieleman, J.; Templin, T.; Sadat, N. et al. (2016) CC

A general consensus exists that as a country develops economically, health spending per capita rises and the share of that spending that is prepaid through government or private mechanisms also rises. However, the speed and magnitude of these changes vary substantially across countries, even at simi ... lar levels of development. In this study, we use past trends and relationships to estimate future health spending, disaggregated by the source of those funds, to identify the financing trajectories that are likely to occur if current policies and trajectories evolve as expected. Methods We extracted data from WHO's Health Spending Observatory and the Institute for Health Metrics and Evaluation's Financing Global Health 2015 report. We converted these data to a common purchasing power-adjusted and inflation-adjusted currency. We used a series of ensemble models and observed empirical norms to estimate future government out-of-pocket private prepaid health spending and development assistance for health. We aggregated each country's estimates to generate total health spending from 2013 to 2040 for 184 countries. We compared these estimates with each other and internationally recognised benchmarks. Findings Global spending on health is expected to increase from US$7·83 trillion in 2013 to $18·28 (uncertainty interval 14·42–22·24) trillion in 2040 (in 2010 purchasing power parity-adjusted dollars). We expect per-capita health spending to increase annually by 2·7% (1·9–3·4) in high-income countries, 3·4% (2·4–4·2) in upper-middle-income countries, 3·0% (2·3–3·6) in lower-middle-income countries, and 2·4% (1·6–3·1) in low-income countries. Given the gaps in current health spending, these rates provide no evidence of increasing parity in health spending. In 1995 and 2015, low-income countries spent $0·03 for every dollar spent in high-income countries, even after adjusting for purchasing power, and the same is projected for 2040. Most importantly, health spending in many low-income countries is expected to remain low. Estimates suggest that, by 2040, only one (3%) of 34 low-income countries and 36 (37%) of 98 middle-income countries will reach the Chatham House goal of 5% of gross domestic product consisting of government health spending. Interpretation Despite remarkable health gains, past health financing trends and relationships suggest that many low-income and lower-middle-income countries will not meet internationally set health spending targets and that spending gaps between low-income and high-income countries are unlikely to narrow unless substantive policy interventions occur. Although gains in health system efficiency can be used to make progress, current trends suggest that meaningful increases in health system resources will require concerted action. Funding Bill & Melinda Gates Foundation. more

Global Fund Board discusses the lessons learned from the Seventh Replenishment and the action plan for the Eighth Replenishment

Independent Observer of Global Fund Aidspan (2023) CC

The Global Fund’s Board meeting on 14-16 November 2023 was its 50th; and among the many issues for information was on resource mobilization. The Board document provided an update on the status of the conversion of pledges and the signing of donor agreements. In addition, it presented the results ... more

Domestic and ODA health financing in developing nations – A closer look on the country level

Tilman Rüppel, Joachim Rüppel medmissio (2024) CC

Explore domestic and ODA health financing data for all developing countries and relevant country groups. Navigate directly to information by clicking on a nation’s name in the country list. Methodology and data sources explained on the two final pages

Tatsächliche und voraussichtliche Entwicklung der genuinen ODA-Leistungen Deutschlands insgesamt und für den Gesundheitsbereich

Tilman Rüppel, Joachim Rüppel medmissio (2024) CC

Die Grafik zur deutschen Entwicklungszusammenarbeit zeigt die Entwicklung der finanziellen Mittel Deutschlands im Zeitraum von 2014 bis 2024. Die absoluten Summen werden als Balken und in Eurobeträgen in Millionen dargestellt, während die Kurvenlinien die entsprechenden Prozentwerte im Verhältnis ... more

medmissio fact sheet - U.S. Economic Power and ODA Contributions for Health

Tilman Rüppel and Joachim Rüppel medmissio (2025) CC

This publication discusses official development assistance (ODA) provided by the USA with a focus on health, HIV/AIDS, tuberculosis and malaria. It also reflects upon ODA by the USA in comparison to other donors and funding targets.

medmissio fact sheet - US-Wirtschaftsmacht und ODA-Beiträge für Gesundheit

Tilman Rüppel and Joachim Rüppel medmissio (2025) CC

Diese Veröffentlichung befasst sich mit der öffentlichen Entwicklungshilfe (Official Development Assistance, ODA) der USA mit Schwerpunkt auf den Bereichen Gesundheit, HIV/AIDS, Tuberkulose und Malaria. Außerdem wird die ODA der USA im Vergleich zu anderen Gebern und Finanzierungszielen betrachte ... more

Building Tax Capacity in Developing Countries

Benitez J.C., Mansour M., Pecho M., et al. International Monetary Fund (IMF) (2023) CC

Tax capacity—the policy, institutional, and technical capabilities to collect tax revenue—is part of a deeper process of state building that is essential for achieving the sustainable development goals. This Staff Discussion Note shows that developing countries have made some progress in revenue ... more

Investment Case - Eighth Replenishment 2025

The Global Fund (2025) CC

To meet our Strategy objectives and get within reach of the 2030 SDG 3 target related to the three diseases, the Global Fund needs to raise US$18 billion for the Eighth Replenishment. That sum is essential to drive the required pace of progress in the fight against HIV, TB and malaria, and to m ... more

Argumentaire d'Investissement - Huitième reconstitution des ressources 2025

Le Fonds mondial (2025) CC

Pour atteindre les objectifs de sa stratégie et se rapprocher de la cible de l’ODD 3 liée aux trois maladies à l’horizon 2030, le Fonds mondial doit réunir 18 milliards de dollars US pour sa huitième reconstitution des ressources. Cette somme est le minimum requis pour faire progresser ... more

Investment Case - Achte Wiederauffüllung 2025 - Kurzüberblick

Der Globale Fonds (2025) CC

Damit wir die Meilensteine der Strategie des Globalen Fonds für 2028 einhalten können und SDG 3 für uns weiter erreichbar bleibt, benötigen wir 18 Milliarden US-Dollar, um die nächste dreijährige Förderperiode des Globalen Fonds finanzieren zu können.

Investment Case - Eighth Replenishment 2025 - Executive Summary

The Global Fund (2025) CC

To deliver on the Global Fund Strategy milestones for 2028 and ensure we keep the SDG 3 target within reach, we need to raise US$18 billion to fund the Global Fund’s next three-year grant cycle.

Argumentos a Favor de la Inversión - Octava Reposición de Recursos 2025 - Resumen ejecutivo

El Fondo Mundial (2025) CC

Si queremos cumplir los hitos de la Estrategia del Fondo Mundial para 2028 y mantener a nuestro alcance la meta del ODS 3, necesitamos recaudar 18.000 millones USD para financiar el próximo ciclo de subvenciones trienal del Fondo Mundial.

Argumentaire d'Investissement - Huitième reconstitution des ressources 2025 - Résumé

Le Fonds mondial (2025) CC

Pour franchir toutes les étapes de la stratégie du Fonds mondial jusqu’en 2028 et nous assurer que la cible de l'ODD 3 reste à notre portée, nous devons mobiliser 18 milliards de dollars US pour notre prochain cycle triennal de subvention.

Investment Case - Auf einen Blick - Achte Wiederauffüllung 2025

Der Globale Fonds (2025) CC

Dies ist ein entscheidender Moment bei der Bekämpfung von HIV, Tuberkulose (TB) und Malaria. Für unsere achte Wiederauffüllung benötigt der Globale Fonds 18 Milliarden US-Dollar, um 23 Millionen Menschenleben zu retten, die Sterberate der drei Krankheiten um 64 % zu senken und am Aufbau einer We ... more

Investment Case - At a glance - Eighth Replenishment 2025

The Global Fund (2025) CC

This is a moment of reckoning in the fight against HIV, tuberculosis (TB) and malaria. For our Eighth Replenishment, the Global Fund needs US$18 billion to save 23 million lives, cut the death rate from the three diseases by 64% and help build a healthier, safer and more equitable world.